Service Predicts Tablet Tooling Sticking Problems - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Service Predicts Tablet Tooling Sticking Problems



I Holland has announced the TSAR Predict service, which offers a solution to stop tablet tooling sticking problems, the company reports. The service examines the API or main component of a formulation and prepares a solution by reviewing factors including Van Der Waals, capillary action and morphology. The service was developed after the completion of a two-year Tableting Science Anti-Stick Research (TSAR) project in collaboration with the University of Nottingham's School of Pharmacy and professionals from the Laboratory of Biophysics and Surface Analysis in the UK. The aim of the project was to investigate and solve the universal tablet-manufacturing problem of sticking. The information has now resulted in a service that forecasts the correct anti-stick PharmaCote coating solution for any formulation.

Source: I Holland

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race

Click here